Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Psilocybin-assisted psychotherapy for opioid tapering in chronic pain
NCT05585229Phase 2Recruiting
- Sponsor
- University of British Columbia
- Start
- Oct 2025
- Primary completion
- Aug 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of psilocybin in opioid use disorder (OUD), chronic pain, sponsored by University of British Columbia. Started Oct 2025; status: recruiting.
02
Drugs
psilocybin
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT05585229.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05585229.